All clinical trials of anti-infective agents have employed microbiologic tests to assess the in vivo activity of the chemotherapeutic agent under study. Similar tests are needed for clinical trails of antiretrovirals. It is the goal of the Virology Core Laboratory of the UCSF ACTU to perform tests known or suspected of measuring in vivo antiretroviral effect in a reproducible, perform tests known or suspected of measuring in vivo antiretroviral effect in a reproducible, rapid and accurate fashion. Currently the tests most widely used for assessing in vivo antiretroviral effect are the serum HIV p24 (core) antigen, and culture of peripheral blood mononuclear cells for HIV. Although changes in the serum concentration of p24 antigen appear to be a good measure of antiretroviral effect with reverse transcriptase inhibitors, simple culture of leukocytes for HIV has not. The ACTG is therefore moving toward quantitative culture of plasma as another marker of in vivo antiretroviral effect, and other tests (e.g. measurement of HIV cDNA or genomic RNA after PCR amplification) are being considered. The UCSF ACTU Core Virology Laboratory has been performing HIV culture and p24 determination since 1987, and has been certified continuously for p24 antigen testing since 1989 and for HIV culture since 1990. In addition, we have experience in some as-yet uncertified procedures such as quantitative microculture of cells and plasma, and PCR quantitation of HIV cDNA and genomic RNA.
The specific aims of the UCSF ACTU Core Virology Laboratory are to perform HIV cultures, p24 antigen quantitation, and other virologic testing as needed for ACTU's for later testing; to maintain our proficiency by participating in ACTG quality assurance programs, and to work with the ACTG nationally to develop and validate other markers of in vivo antiretroviral effects.

Project Start
1998-01-01
Project End
1998-12-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
12
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Kempen, John H; Sugar, Elizabeth A; Varma, Rohit et al. (2014) Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections. Ophthalmology 121:2317-24
Kozak, Igor; Vaidya, Vijay; Van Natta, Mark L et al. (2014) The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis. Invest Ophthalmol Vis Sci 55:4304-12
Amorosa, Valerianna K; Luetkemeyer, Anne; Kang, Minhee et al. (2013) Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. HIV Clin Trials 14:274-83
Jabs, Douglas A; Ahuja, Alka; Van Natta, Mark et al. (2013) Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 120:1262-70
Gangaputra, Sapna; Drye, Lea; Vaidya, Vijay et al. (2013) Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 155:206-212.e5
Kempen, John H; Sugar, Elizabeth A; Lyon, Alice T et al. (2012) Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome. Ophthalmology 119:2343-50
Gangaputra, Sapna; Kalyani, Partho S; Fawzi, Amani A et al. (2012) Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with disease-associated factors and mortality. Am J Ophthalmol 153:434-444.e1
Kalyani, Partho S; Fawzi, Amani A; Gangaputra, Sapna et al. (2012) Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with visual function. Am J Ophthalmol 153:428-433.e1
Sezgin, Efe; van Natta, Mark L; Ahuja, Alka et al. (2011) Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus. Am J Ophthalmol 151:999-1006.e4
Puhan, Milo A; Ahuja, Alka; Van Natta, Mark L et al. (2011) Interviewer versus self-administered health-related quality of life questionnaires - does it matter? Health Qual Life Outcomes 9:30

Showing the most recent 10 out of 82 publications